Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × tremelimumab × Clear all

NCT03298451 2026-01-14

HIMALAYA

Phase 3 Active not recruiting

1,324 enrolled 31 charts 1 FDA

Gastrointestinal

Carcinoma, Hepatocellular

NCT06921785 2026-01-09

ARTEMIDE-HCC01

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05557838 2025-02-07

TREMENDOUS

Phase 3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05301842 2025-01-15

EMERALD-3

Phase 3 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms